User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)

Primary tabs

Giaccone, Giuseppe [Vrije Universiteit Medical Center] Debruyne, Channa [EORTC] Felip, Enriqueta [Vall d'Hebron University Hospital] Chapman, Paul B. [Memorial Sloan-Kettering Cancer Center] Grant, Stefan C. [Sir Charles Gairdner Hospital] Legrand, Catherine [UCL]
Document type Article de périodique (Journal article) – Article de recherche
Publication date 2005
Language Anglais
Journal information "Journal of Clinical Oncology" - Vol. 23, no. 28, p. 6854-6864 (2005)
Peer reviewed yes
Publisher American Society of Clinical Oncology ((United States) Alexandria)
issn 0732-183X
e-issn 1527-7755
Publication status Publié
Affiliation UCL - EUEN/STAT - Institut de statistique
Links
Bibliographic reference Giaccone, Giuseppe ; Debruyne, Channa ; Felip, Enriqueta ; Chapman, Paul B. ; Grant, Stefan C. ; et. al. Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). In: Journal of Clinical Oncology, Vol. 23, no. 28, p. 6854-6864 (2005)
Permanent URL http://hdl.handle.net/2078.1/90359